|
Aug 8
|
DraftKings upgraded, Home Depot downgraded: Wall Street's top analyst calls
|
|
Jun 9
|
Novocure Breaks a Major Support Zone: What Now?
|
|
Jun 7
|
Why Shares of Zai Lab Are Dropping Wednesday
|
|
Jun 6
|
Novocure Crashes 43% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
|
|
Jun 6
|
Novocure Stock Gets Relative Strength Rating Upgrade, Then Drops +40%
|
|
Jun 6
|
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
|
|
Jun 6
|
These 2 Nasdaq Stocks Are Plunging. Here's Why
|
|
Jun 6
|
Why NovoCure Stock Is Crashing Today
|
|
Jun 6
|
UPDATE 2-Novocure's lung cancer device extends survival in late-stage study
|
|
Jun 6
|
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
|
|
Jun 6
|
LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
|